Paper41379296
Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review.
Manoharan S and 1 other. Mol Divers, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review. Papers, record 41379296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41379296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Quinazolines | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| Structure-Activity Relationship | |
| Animals |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 111-2536-319/2K23/1 | Council of Scientific and Industrial Research, India | PubMed | ||
| 5/8-4/15/Env/2020-NCD-II | ICMR ad hoc | PubMed | ||
| CRD/2024/000898 | ASEAN-India Collaborative R&D Scheme | PubMed | ||
| ANRF/IRG/2024/001655/LS | ANRF-IRG Scheme | PubMed | ||
| CMRG/3005/H3/2024/080 | CMRG Scheme | PubMed |
Source PubMed
References95
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27231098 | Synthesis and Anticonvulsant Activity of N-(Substituted)-1-methyl-2,4-dioxo-1,2-dihydroquinazoline-3(4H)-carboxamides. | Arch Pharm (Weinheim) | 2016 | https://conductscience.org/library/papers/27231098 | PubMed |
| 2 | 29648554 | Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity. | Org Biomol Chem | 2018 | https://conductscience.org/library/papers/29648554 | PubMed |
| 3 | 38995264 | An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013-2023). | J Med Chem | 2024 | https://conductscience.org/library/papers/38995264 | PubMed |
| 4 | 7592939 | Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7592939 | PubMed |
| 5 | 34934125 | Synthesis and multifaceted pharmacological activity of novel quinazoline NHE-1 inhibitors. | Sci Rep | 2021 | https://conductscience.org/library/papers/34934125 | PubMed |
| 6 | 35805035 | Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35805035 | PubMed |
| 7 | 23583850 | Synthesis, anticonvulsant, antioxidant and binding interaction of novel N-substituted methylquinazoline-2,4(1H,3H)-dione derivatives to bovine serum albumin: a structure-activity relationship study. | Spectrochim Acta A Mol Biomol Spectrosc | 2013 | https://conductscience.org/library/papers/23583850 | PubMed |
| 8 | 29342416 | Identification of novel quinazolinedione derivatives as RORγt inverse agonist. | Bioorg Med Chem | 2018 | https://conductscience.org/library/papers/29342416 | PubMed |
| 9 | 36295082 | Guanidine Derivatives of Quinazoline-2,4(1H,3H)-Dione as NHE-1 Inhibitors and Anti-Inflammatory Agents. | Life (Basel) | 2022 | https://conductscience.org/library/papers/36295082 | PubMed |
| 10 | 6800533 | Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6800533 | PubMed |
| 11 | 24856180 | Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents. | Bioorg Med Chem | 2014 | https://conductscience.org/library/papers/24856180 | PubMed |
| 12 | 17318184 | Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation. | EMBO J | 2007 | https://conductscience.org/library/papers/17318184 | PubMed |
| 13 | 27750154 | Synthesis, anti-varicella-zoster virus and anti-cytomegalovirus activity of quinazoline-2,4-diones containing isoxazolidine and phosphonate substructures. | Eur J Med Chem | 2017 | https://conductscience.org/library/papers/27750154 | PubMed |
| 14 | 22197388 | 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists. | Bioorg Med Chem Lett | 2012 | https://conductscience.org/library/papers/22197388 | PubMed |
| 15 | 7493607 | The 5-HT2 receptor antagonist, pelanserin, inhibits alpha 1-adrenoceptor-mediated vasoconstriction in vitro. | Eur J Pharmacol | 1995 | https://conductscience.org/library/papers/7493607 | PubMed |
| 16 | 35682608 | Discovery of Novel 3-Hydroxyquinazoline-2,4(1H,3H)-Dione Derivatives: A Series of Metal Ion Chelators with Potent Anti-HCV Activities. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682608 | PubMed |
| 17 | 30002297 | Quinazolinone-Amino Acid Hybrids as Dual Inhibitors of EGFR Kinase and Tubulin Polymerization. | Molecules | 2018 | https://conductscience.org/library/papers/30002297 | PubMed |
| 18 | 32582763 | Novel Quinazolin-2,4-Dione Hybrid Molecules as Possible Inhibitors Against Malaria: Synthesis and in silico Molecular Docking Studies. | Front Mol Biosci | 2020 | https://conductscience.org/library/papers/32582763 | PubMed |
| 19 | 1080313 | Metabolism of 1-(3-trifluoromethylphenyl)-3-(2-hydroxyethyl) quinazoline-2,4(1H,3H)-dione (H-88). I. Species differences in metabolism. | Xenobiotica | 1975 | https://conductscience.org/library/papers/1080313 | PubMed |
| 20 | 32510731 | Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2,4(1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors. | Arch Pharm (Weinheim) | 2020 | https://conductscience.org/library/papers/32510731 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42796451 | Synthesis of Quinazoline Derivatives and Mechanistic Approaches in Lung and Breast Cancers. | Molecules | 2026 | https://conductscience.org/library/papers/42796451 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41379296
GET https://conductscience.org/api/papers/v1/41379296/references?page=2